Suppr超能文献

在竞争性 CD45.1/CD45.2 同基因骨髓移植模型中存在性别特异性再重建偏差。

A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model.

机构信息

University of Cambridge, Department of Medicine, Cambridge, CB2 0QQ, United Kingdom.

Queen's University, Department of Biomedical and Molecular Sciences, Kingston, K7L 3N6, Canada.

出版信息

Sci Rep. 2017 Jun 14;7(1):3495. doi: 10.1038/s41598-017-03784-9.

Abstract

Allelic variants of the pan-haematopoietic cell marker CD45, identified as CD45.1 and CD45.2, have been established as a marker system to track haematopoietic cells following congenic mouse bone marrow transplants. Despite the frequent use of this model for studying the impact of genetic modifications on relative differentiation potential, it is now evident that a bias exists in CD45.1 versus CD45.2 cell reconstitution. While this bias has been demonstrated by reduced reconstitution potential in B cells of CD45.1 origin, differences in the development of other lymphocytes, as well as the impact of sex on this bias, remain uncertain. We performed bone marrow transplants with wild-type CD45.1 and CD45.2 donor cells, and characterised haematopoietic cell reconstitution in dual-expressing CD45.1/2 host mice. We report an increase in CD45.2 reconstitution in the bone marrow that persists in the spleen, thymus and blood. Through the use of CD45.1/2 hosts, we demonstrate the intrinsic bias towards CD45.2 reconstitution is independent of an immunogenic response to the CD45.1 epitope. Furthermore, we identify a sex-specific difference in reconstitution efficiencies, with female mice exhibiting a greater bias towards CD45.2 reconstitution than males. This work sheds new light on the limitations of the CD45.1/CD45.2 congenic system for tracking lymphocyte development.

摘要

造血细胞通用标志物 CD45 的等位基因变体被鉴定为 CD45.1 和 CD45.2,已被确立为用于跟踪经过基因同源骨髓移植后造血细胞的标记系统。尽管该模型常用于研究遗传修饰对相对分化潜能的影响,但现在显然存在 CD45.1 与 CD45.2 细胞重建的偏差。虽然这种偏差已通过 CD45.1 来源的 B 细胞重建潜力降低得到证明,但其他淋巴细胞的发育差异以及性别对这种偏差的影响仍不确定。我们使用野生型 CD45.1 和 CD45.2 供体细胞进行骨髓移植,并在双表达 CD45.1/2 宿主小鼠中表征造血细胞重建。我们报告骨髓中 CD45.2 重建增加,并持续存在于脾脏、胸腺和血液中。通过使用 CD45.1/2 宿主,我们证明了 CD45.2 重建的固有偏差独立于对 CD45.1 表位的免疫反应。此外,我们确定了重建效率的性别特异性差异,雌性小鼠比雄性小鼠表现出对 CD45.2 重建更大的偏差。这项工作为追踪淋巴细胞发育的 CD45.1/CD45.2 同基因系统的局限性提供了新的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c8/5471196/3b63110378e6/41598_2017_3784_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验